Summary of precautions while taking tenofovir alafenamide tablets (Vemlidy)

Tenofovir alafenamide fumarate tablets (Vemlidy, Vemlidy) is an oral nucleotide reverse transcriptase inhibitor, mainly used to treat patients with chronic hepatitis B (CHB). It improves liver function and reduces the progression of liver fibrosis by inhibiting the replication of hepatitis B virus (HBV). During the medication process, patients need to follow strict medication regulations to ensure drug efficacy and medication safety.

Patients should insist on taking the medication on time every day, and it is usually recommended to take it orally during or after meals to improve drug absorption and tolerance. Do not stop medication at will or adjust the dose on your own, as irregular medication may lead to viral rebound or the development of drug resistance. If you miss a dose, you should take it as soon as you remember. However, if the next dose is close, you should skip it to avoid taking a double dose at one time.

Patients need to have liver and kidney function monitored regularly during medication. Although Veride is generally well tolerated, some patients may experience adverse reactions such as abnormal renal function or increased blood lactate. For patients with existing renal function impairment, the dosage should be adjusted under the guidance of a doctor, and changes in serum creatinine and glomerular filtration rate (GFR) should be paid close attention to prevent drug accumulation leading to toxic reactions.

While taking Veride, patients should avoid concurrent use of drugs or health products that are obviously toxic to the liver and kidneys, such as certain antibiotics, analgesics and herbal supplements, to reduce the risk of drug interactions. In addition, you should maintain a healthy lifestyle, including a low-salt diet, smoking cessation and alcohol restriction, regular work and rest, and moderate exercise to achieve the best effect of the drug. Overall, scientific management of medication, regular monitoring of indicators and healthy living habits are key measures to ensure the safety and effectiveness of tenofovir alafenamide tablets in the treatment of hepatitis B.

Reference link:https://www.drugs.com